8.80

6.15% 0.51

Optimizerx Corp (OPRX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Optimizerx Corp stock is traded at $8.80, with a volume of 50,325. It is up +6.15% in the last 24 hours and up +16.40% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

Previous Close:

$8.29

Open:

$8.2

24h Volume:

50,325

Relative Volume:

0.31

Market Cap:

$165.76M

Revenue:

$107.35M

Net Income/Loss:

$6.84M

P/E Ratio:

24.92

EPS:

0.3532

Net Cash Flow:

$14.64M

1W Performance:

+5.01%

1M Performance:

+16.40%

6M Performance:

+37.50%

1Y Performance:

-56.84%

1-Day Range:

$8.11

$8.80

1-Week Range:

$8.14

$8.59

52-Week Range:

$4.54

$22.25

Optimizerx Corp Stock (OPRX) Company Profile

Name

Optimizerx Corp

Sector

Healthcare (1051)

Industry

Health Information Services (41)

Phone

248-651-6558

Address

260 CHARLES STREET, WALTHAM, MI

Employee

133

Twitter

@OpRxTweets

Next Earnings Date

2026-11-05

Latest SEC Filings

OPRX's Discussions on Twitter

Compare OPRX vs VEEV, TEM, BTSG, HNGE, HQY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OPRX Optimizerx Corp	8.80	165.76M	107.35M	6.84M	14.64M	0.3532
VEEV Veeva Systems Inc	311.15	50.38B	3.32B	941.65M	1.64B	5.6161
TEM Tempus Ai Inc	70.14	12.73B	1.36B	-302.91M	-219.93M	-1.7182
BTSG Brightspring Health Services Inc	62.17	12.30B	13.65B	169.86M	412.12M	1.0758
HNGE Hinge Health Inc	105.42	8.51B	646.34M	-512.40M	202.76M	-6.6871
HQY Healthequity Inc	92.47	7.65B	1.34B	230.70M	440.96M	2.6695

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-29-26	Resumed	B. Riley Securities	Buy
Jan-08-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-20-24	Initiated	Stephens	Equal-Weight
Jul-25-24	Resumed	B. Riley Securities	Buy
Apr-04-24	Initiated	JMP Securities	Mkt Outperform
Jan-03-24	Initiated	Barclays	Equal Weight
Feb-02-23	Resumed	B. Riley Securities	Buy
Nov-01-22	Initiated	Stifel	Buy
Jul-15-22	Initiated	SVB Leerink	Outperform
Oct-18-21	Resumed	B. Riley Securities	Buy
Apr-13-21	Initiated	RBC Capital Mkts	Outperform
Jan-03-19	Initiated	William Blair	Outperform

View All

Optimizerx Corp Stock (OPRX) Latest News

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com Canada

Oct 02, 2026

Form 4 OPTIMIZERx Corp For: 2 October By Investing.com - Investing.com UK

Oct 02, 2026

Stock vesting triggers tax withholding at OptimizeRx (OPRX): 414 shares at $8.39 each. - Stock Titan

Oct 02, 2026

Sep 23, 2026

Will OPRX's OpenPath Deal Help TTD Capture More Healthcare Ad Dollars? - Zacks Investment Research

Sep 23, 2026

Sep 20, 2026

OptimizeRx CorporationCommon Stock (Nasdaq:OPRX) Detailed Stock Data - The Chronicle-Journal

Sep 18, 2026

Sep 17, 2026

OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.com.au

Sep 17, 2026

Sep 14, 2026

One prompt now builds patient and doctor audiences. OptimizeRx expanded the tool. - Stock Titan

Sep 14, 2026

Sep 08, 2026

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference - marketscreener.com

Sep 08, 2026

A 10th annual growth conference is set for New York, with OptimizeRx taking part. - Stock Titan

Sep 08, 2026

Sep 04, 2026

OPTIMIZERx Corp (NASDAQ: OPRX) Share Price, OPRX Stock News, OPRX Share Price & Updates - kalkine.ca

Sep 04, 2026

Sep 02, 2026

OptimizeRx (OPRX) insider stock withheld for taxes - Stock Titan

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com Canada

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor - investing.com

Sep 02, 2026

OptimizeRx Appoints Former Johnson & Johnson Executive Troy Sarich as Company Advisor - Quiver Quantitative

Sep 02, 2026

OptimizeRx appoints Troy Sarich as company advisor By Investing.com - Investing.com UK

Sep 02, 2026

OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor - Yahoo Finance UK

Sep 02, 2026

Aug 26, 2026

OptimizeRx Corp. (NASDAQ:OPRX) Given Average Rating of "Moderate Buy" by Analysts - marketbeat.com

Aug 26, 2026

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) COO keeps 25,187 shares after RSU tax withholding - Stock Titan

Aug 24, 2026

OptimizeRx (OPRX) records insider share trade - Stock Titan

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) insider logs new stock trade - Stock Titan

Aug 24, 2026

OptimizeRx (NASDAQ: OPRX) reports new insider share transaction - stocktitan.net

Aug 24, 2026

Aug 23, 2026

OPRX | OptimizeRx Corporation Common Stock FinancialsRevenue Breakdown - Quiver Quantitative

Aug 23, 2026

Aug 19, 2026

OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript - AOL.com

Aug 19, 2026

OptimizeRx (OPRX) EPS and Revenue: Profit Per Share Clears Its Benchmark in the Current Update; Closing Move - vinanet.vn

Aug 19, 2026